A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study.

Journal Information

Full Title: Diabetol Metab Syndr

Abbreviation: Diabetol Metab Syndr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participate“The study in Mexico was approved by the regulatory authorities (Cofepris) and the research and ethics committee of each participating center. All participants provided written informed consent prior to inclusion. A total of 32 sites (6 specialized diabetes treatment centers and 26 primary care centers) distributed all around Mexico with 91 investigators and assistant investigators participated in the study. Patients were recruited from December 2018 to September 2019.” Consent for publicationJosé L. Arenas-León; Enrique C. Morales-Villegas; Ernesto G. Cardona-Muñoz; Marco A. Alcocer-Gamba; Juan P. Ramirez-Contreras; Aleida Y. Contreras-Sandoval; Guillermo González-Galvez give their full consent for publication. Competing interestsJosé L. Arenas-León ; Enrique C. Morales-Villegas; Ernesto G. Cardona-Muñoz; Marco A. Alcocer-Gamba and Guillermo González-Galvez have not competing interests for this publication. Juan P. Ramirez-Contreras and Aleida Y. Contreras-Sandoval are employees of Novonordisk. Competing interests José L. Arenas-León ; Enrique C. Morales-Villegas; Ernesto G. Cardona-Muñoz; Marco A. Alcocer-Gamba and Guillermo González-Galvez have not competing interests for this publication. Juan P. Ramirez-Contreras and Aleida Y. Contreras-Sandoval are employees of Novonordisk."

Evidence found in paper:

"Funding Editorial assistance was funded by Novonordisk. Novonordisk did not have any impact or influence on data acquisition, analyses or interpretation of the results."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025